Clinical trials
Leukemia, Myeloid, Acute trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2009 | 1 |
| 2013 | 1 |
| 2015 | 3 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Active, not recruiting | 5 |
| Recruiting | 4 |
| Unknown status | 3 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 6 |
| Novartis Pharmaceuticals | 5 |
| AbbVie | 3 |
| Janssen Research & Development, LLC | 2 |
| Astellas Pharma Global Development, Inc. | 1 |
| Celgene | 1 |
| Cumhuriyet University | 1 |
| Ege University | 1 |
| Gazi University | 1 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 27 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 8 |
| Leukemia | 6 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Lymphoma, Non-Hodgkin | 5 |
| Multiple Myeloma | 5 |
| Neoplasms | 5 |
| Blast Crisis | 4 |
| Burkitt Lymphoma | 4 |
| Hodgkin Disease | 4 |
Trials
Showing 26 to 27 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.